Using an Improvement Model to Reduce Adverse Drug Events in VA Facilities

Author： Weeks William B.   Mills Peter D.   Dittus Robert S.   Aron David C.   Batalden Paul B.  

Publisher： Joint Commission Resources

ISSN： 1553-7250

Source： Joint Commission Journal on Quality and Patient Safety, Vol.27, Iss.5, 2001-05, pp. : 243-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The burden of adverse drug events

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 785-787

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduction in Anticoagulation-Related Adverse Drug Events Using a Trigger-Based Methodology

By Lederer Jim   Best Diana  

Joint Commission Journal on Quality and Patient Safety, Vol. 31, Iss. 6, 2005-06 ,pp. : 313-318

Joint Commission Resources

Access to resources Recommend Favorite

Adverse drug reactions – examples of detection of rare events using databases

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 855-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐specific risk factors of adverse drug events in adult inpatients – evidence detected using the Global Trigger Tool method

By  

JOURNAL OF CLINICAL NURSING, Vol. 24, Iss. 3-4, 2015-02 ,pp. : 582-591

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eliminating Adverse Drug Events at Ascension Health

By Butler Kerry   Mollo Paul   Gale Jane L.   Rapp Deborah A.  

Joint Commission Journal on Quality and Patient Safety, Vol. 33, Iss. 9, 2007-09 ,pp. : 527-536

Joint Commission Resources

Access to resources Recommend Favorite